Kharfan-Dabaja MA, Kumar A, Ayala E, Aljulf M, Nishibori T, Marsh R, et al. Standardization of definitions of hematopoietic recovery, graft rejection, graft failure, graft dysfunction, and donor chimerism in allogeneic hematopoietic cell transplantation: a report on behalf of the American Society for Transplantation and Cell Therapy. Transplant cell sir. 2021;27:642–9.
Ozdemir ZN, Civriz Bozdag S. Graft failure after allogeneic hematopoietic stem cell transplantation. Transfer Beyond Science 2018;57:163–7.
Alcazer V, Peffault de Latour R, Ader F, Labussiere-Wallet H. Graft failure after allogeneic hematopoietic stem cell transplantation: definition and risk factors. Cancer in bulls. 2019;106:574–83.
Mattsson J, Ringden O, Storb R. Graft failure after allogeneic hematopoietic cell transplantation. Bio blood bone marrow transplant. 2008;14:165–70.
Ferra C, Sanz J, Díaz-Perez MA, Morgades M, Gayoso J, Cabrera JR et al. Graft failure outcomes after allogeneic stem cell transplantation: a study of 89 patients. Leuclin lymphoma. 2015;56:656–62.
Locatelli F, Lucarelli B, Merli P. Current and future approaches to treating graft failure after allogeneic hematopoietic stem cell transplantation. Opin pharmacist expert. 2014;15:23–36.
Nagler A, Labopin M, Swoboda R, Kulagin A, Velardi A, Sanz J, et al. Long-term outcomes of a second allogeneic hematopoietic stem cell transplant (HSCT2) for primary graft failure in patients with acute leukemia in remission: a study representing the Acute Leukemia Working Group of the European Society for Blood and Marrow Transplantation. Bone marrow transplantation. 2023;58:1008–16.
Singh H, Nikiforow S, Li S, Ballen KK, Spitzer TR, Soiffer R, Outcomes and management strategies for graft failure after other umbilical cord blood transplants. J hematol. 2014;8912:1097–101.
London G, Saliba RM, Khoury I, Giralt S, Zhang K, Jabour E, et al. Long-term follow-up of patients who experienced graft failure after allogeneic progenitor cell transplantation. Single institution analysis results. Bio blood bone marrow transplant. 2008;14:859–66.
Sun Y, Xu L, Liu D, Zhang X, Wang Y, Han W et al.Second transplantation in 22 patients with graft failure after initial allogeneic stem cell transplantation. Chinese snow leaf snow zhi. 2014;35:673–7.
Chen J, Pang A, Zhao Y, Liu L, Ma R, Wei J et al. Primary graft failure after allogeneic hematopoietic stem cell transplantation: risk factors, treatment, and outcome. Hematology. 2022;271:293–9.
Olson RF, Logan BR, Chaudhry S, Zhu X, Akpek G, Bolwell BJ, et al. Primary graft failure after myeloablative allogeneic hematopoietic cell transplantation for hematologic malignancies. leukemia. 2015;29:1754–62.
Wang Y, Liu DH, Liu KY, Xu LP, Zhang XH, Han W, et al. Long-term follow-up of haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for the treatment of leukemia: 9 years at a single institution. experience. cancer. 2013;119:978–85.
Aversa F, Terenzi A, Tabilio A, Falzetti F, Carotti A, Baranti S, et al. Fully haplotype-discordant hematopoietic stem cell transplantation: a phase II study in patients with acute leukemia at high risk of recurrence. J Clin Oncol. 2005;23:3447–54.
Luznik L, O’Donnell PV, Symons HJ, Chen AR, Leffell MS, Zahurak M, et al. HLA haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose posttransplant cyclophosphamide. Bio blood bone marrow transplant. 2008;14:641–50.
Gianmarco S, Raiola AM, di Grazia C, Bregante S, Guarandi F, Barrardo R Second haploidentical stem cell transplantation for other primary graft failure. Bone marrow transplantation. 2021;56:1291–6.
Kazuya Harada, Yuko Najima, Masami Kato, Shinzo Fuji, Ajin Shinohara, Hiroshi Nakamae et al. Results of salvage haploidentical transplantation using post-transplant cyclophosphamide for graft failure after allogeneic hematopoietic stem cell transplantation. Int J Hematol. 2022;116:744–53.
Prata PH, Resche-Rigon M, Blaise D, Socie G, Rohrlich PS, Milpied N, et al. Results of salvage of haploidentical transplantation with post-transplant cyclophosphamide to save patients with graft failure: A report on behalf of the French-speaking Bone Marrow Transplantation and Cell Therapy Association. Bio blood bone marrow transplant. 2019;25:1798–802.
Sun YQ, Wang Y, Wang FR, Yan CH, Cheng YF, Chen YH et al. Graft failure in patients with hematological malignancies: successful rescue with a second transplant from a different haploidentical donor. front med. 2021;8:604085.
Tetsuya Onuma, Kazuto Harada, Tetsuya Kondo, Masato Mashiko, Naoya Uchida, Tetsuya Yano, et al Salvage of single-unit unrelated cord blood transplantation for graft failure after initial allogeneic transplantation in adult acute myeloid leukemia: Outcomes over the past 20 years. trends. Bone marrow transplantation. 2022;57:1848–50.
Kazuto Harada, Shun Fuji, Shun Seo, Jun Kanda, Tetsu Ueki, Aya Kimura et al. Comparison of outcomes after haploidentical transplantation and cord blood salvage transplantation for graft failure after allogeneic hematopoietic stem cell transplantation. Bone marrow transplantation. 2020;55:1784–95.
Wegener D, Lang P, Paulsen F, Weidner N, Zips D, Ebinger M, et al. A realignment regimen based on immunosuppressive whole-node irradiation after graft rejection or graft failure in pediatric patients treated with myeloablative allogeneic hematopoietic cell transplantation. Int J Radiat Oncol Biol Phys. 2019;104:137–43.
Kliman D, Billmon I, Kwan J, Bryce E, Micklethwaite K, Panicker S, et al. Salvage of haploidentical peripheral blood stem cell transplantation for engraftment failure: a single-center case series. Intern Med J. 2018;48:988–91.
Guardiola P, Quentz M, Garvan F, Blaise D, Reifers J, Attar M, et al. Second early allogeneic stem cell transplantation for graft failure in acute leukemia, chronic myeloid leukemia, and aplastic anemia. French Bone Marrow Transplant Association. Br J Hematol. 2000;111:292–302.
Teltschik HM, Heinzelmann F, Gruhn B, Feuchtinger T, Schlegel P, Schumm M, et al. Treatment of graft failure with TNI-based reconditioning and haploidentical stem cells in pediatric patients. Br J Hematol. 2016;175:115–22.
Yellow XJ. Overcoming graft failure after haploidentical transplantation: is it possible? Best Pract Res Clin Hematol. 2021;34:101255.
Prabahran A, Koldej R, Chee L, Ritchie D. Clinical features, pathophysiology, and treatment of graft function decline after allogeneic stem cell transplantation. Blood Adv. 2022;6:1947–59.
Arabic
Chinese (Simplified)
Dutch
English
French
German
Italian
Portuguese
Russian
Spanish